\n
\;
\n
MEETING NO TICE
\n
Med-QUEST Drug Use Review (DUR) Board
\n
\;
\n
Wednesday\, August 12\, 2026\, 12 Noon
\n
Microsoft Teams Meeting Informatio n below
\n
The public may a lso attend the meeting at Kakuhihewa Building\, 601 Kamokila Blvd.\, Kap olei\, Hawaii\, Conference Room 511A\, where an audiovisual connection w ill be provided for the public to view and participate in the meeting.\n
\;
\n
AGENDA&n bsp\;
\n
I. \; \; \; \; \; \; \; \; \; \; \; \; \; \; \; \; \; \;&n bsp\; Call to Order\; Roll Call and Determination of Quoru m
\n

~~II. \; \; \; \; \; \; \; \;&n bsp\; \; \; \; \; \; \; \; \;~~ Approval of Minutes from the May 13\, 2026\, DUR Board Meeting

III. \; \; \; \; \; \; \; \; \;& nbsp\; \; \; \; \; \; Old business

\;A. \; \; \; \; \; Board members&rsquo\; extension of terms approved\; Vacant pharmacist member\, searching for pharmacist with neighbor island community pharmacy backgr ound

\;B. \; \; \; \; \; Update on DUR Board member bylaws with practicing dentist member

~~\;C. \; \; \; \; \;~~ ~~< !--[endif]-->U.S. Cen ters for Medicare and Medicaid Annual DUR Survey~~

\n
1. \;&n bsp\; \; \; \; Prescription Drug Monitoring Pr ogram (PDMP) updates
\n
2. \; \; \; \; \; Retrospective DUR program
\n
\;D. \; \; \; \; Dental Program
\n
1. \; \; \; \; \; Outlier controlled substance prescri ber
\n
\;E. \; \; \; \; \; State of Hawaii Organ and Tissue Transplant program
\n
1. \; \; \; \; \; Expensive drug claims revie w
\n
IV. \; \; \; \; \; \; \; \;&n bsp\; \; \; \; \; \; \; New Busine ss
\n
\;A. \; \; \; \; \; Educational Outreach Quarterly FFS provider bulletin
\n
1. \; \; \; \; \; Resources for pain manageme nt prescribing considerations: \;
\n

a. \; \; \;& nbsp\; \; Th e CDC Clinical Practice Guideline for Prescribing Opioids for Pain &mdas h\; United States\, 2022 | MMWR \;ht tps://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm \;provi des CDC's most updated recommendations for clinicians providing pain car e for outpatients aged 18 years and over. \; \;The guidance addr esses four areas: \; \;1) determining whether to initiate opioid s for pain\, 2) selecting opioids and determining opioid dosages\, 3) de ciding duration of initial opioid prescription and conducting follow-up\ , and 4) assessing risk and addressing potential harms of opioid use.

b. \; \; \; \; \; Acute Dental Pain Management Guideline | American Dental Association \;https://www.ada.org/resources/research/ science/evidence-based-dental-research/pain-management-guideline&nbs p\;provides ADA's most updated guidelines on acute dental pain managemen t for adults and adolescents (2024) and pediatrics (2023)\, including ev idence-based resources for the clinician.

2. \; \;&n bsp\; \; \; Safe opioid prescribing practices:&nbs p\; \;

a. \; \; \; \; \; https://hawaii.pmpaware.net& nbsp\;Under the Federal SUPPORT Act (Substance Use-Disorder Prevention t hat Promotes Opioid Recovery and Treatment for Patients and Communities Act)\, Medicaid providers must check\, before prescribing a controlled s ubstance\, the prescription drug history of a Medicaid beneficiary in th e Hawaii PDMP (AKA HI PMP AWARxE)

b. \; \; \; \; \; https://stacks.cdc.gov/view/cdc/38481/cdc_38481_DS1.pd f \;Download URL for CDC guidelines: \; \;Calculating To tal Daily Dose of Opioids for Safer Dosage

c. \; \;&nb sp\; \; \; \; CDC Updated 2022 Morphine Millig ram Equivalents Calculator - GlobalRPH \;https://globalr ph.com/medcalcs/morphine-milligram-equivalents-calculator/ \;cal culator provides estimates of equianalgesic dose of morphine for common opioids

3. \; \; \; \; \; Naloxone nasal:

a. \; \; \; \; \; Naloxone nasal is also available at various locations across the s tate of Hawaii through vending machines\, at no charge to the public.&nb sp\; \;Check out Hawaii Health &\; Harm Reduction Center website at \;https://www.hhhrc.org \;for more information on vending machine locations and other information on nalox one nasal accessibility and usage. \;

4. \; \;&n bsp\; \; \; Safe disposal of unwanted medications

a. \; \; \; \; \; Take Back Program at \;ht tps://manoa.hawaii.edu/c3od2a/take-back/ \;shows locations on ev ery island to drop off unneeded or found medications

b. \; \; \; \; \; If a medication take-back pro gram is not available nearby\, go to \;https://www.fda.gov/drugs/safe-disposal-medicines/disposal-unused- medicines-what-you-should-know \;for medications that can be saf ely flushed down the toilet. \; \;This list includes a small num ber of medicines that may be especially harmful and\, in some cases\, fa tal with just one dose if they are consumed by pets or by someone other than the person for whom the medicine was prescribed.

c. \ ; \; \; \; \; \; If the medication is not on the &ldquo\;Flush list&rdquo\;\, mix with dirt\, cat litter\, or coffee grounds. \; \;Then seal in a container or plastic bag and throw away in your household rubbish.

\;B. \; \; \; \; \; Hepatitis C treatment guidelines and health plan requirements

\;C. \; \; \; \ ; \; Potential effects of utilization management from H.R. 1 Act community engagement requirements

V. \; \;&n bsp\; \; \; \; \; \; \; \; \; \;&nbs p\; \; \; \; \; Public Testimony regarding topics pertinent to the FFS DUR Board\, limited to 3 minutes per speake r

VI. \; \; \; \; \; \; \; \;&n bsp\; \; \; \; \; \; \; Next meeti ng will \; \;be held on Wednesday\, November 18\, 2026

VII. \; \; \; \; \; \; \; \; \; \; \; \; \; Adjourn

All interested persons shall have an opportunity to submit data\, views\, or arguments\, in writing\, and an opportunity to present oral testimony t o any agenda item. \; \;Any person providing oral testimony is r equested to submit the remarks\, or a summary of the remarks\, in writin g to the board\, no later than 48 hours prior to the meeting and shall s tate the item on which the testimony is being presented. \; \;Th e board provides for oral testimony of three minutes.

\ ;

Written testim ony may be emailed to MQDDURBoard@dhs.hawaii.gov or sent by U.S. Postal Mail to Department of Human Services\, Med-QUEST Division\, Attn: \; \;Drug Use Review Board\, P.O. Box 700190\, Kapolei\, HI 96709-0190 .

NOTICE: \; \;Written testimony submitted will be made publ ic record and any contact information contained therein will be availabl e for public inspection and copying. \; \;Please do not include information in your testimony that you do not want to be disclosed to th e public.

NOTE: \; \;If you need auxiliary aid/service or ot her accommodation due to disability or limited English proficiency\, ple ase contact: \; \;Med-QUEST Division at (808) 692-8124 (voice)\; or 711 (TTY) or by email at MQDDURBoard@dhs.hawaii.gov by 12:00 p.m. on Monday\, August 10\, 2026. Requests made as early as possible have a gr eater chance of being fulfilled due to a limited number of communication access providers.

TEAMS VIRTUAL MEETING INFORMATION\n

Topic: \;&nbs p\; \; \; \; \; \; \; \; \; \; \ ; \; \; \;Med-QUEST DUR Board Meeting

Date/Time: \; \; \;& nbsp\; \; \;August 12\, 2026\, 12:00 noon (HST)

&nbs p\;

Regi ster in advance for this meeting:

https://events.gcc.teams.microsoft.com/event/61990eac-11d3-490d-99d 9-475433cd67c1@3847dec6-63b2-43f9-a6d0-58a40aaa1a10

\;*Note\, virtual me eting will be hosted via \;Teams \;Application

Date:: Wednesday\, 08/12/2026
Start Time:: 12:00 PM
Place:: Kakuhihewa Buildin g\, 601 Kamokila Boulevard\, Conference Room 511A\, Kapolei
\n

Agenda

MEETING NOTICE\n

Med-QUEST Drug Use Review (DUR) Board

W ednesday\, August 12\, 2026\, 12 Noon

Microsoft Teams Meeting Information below

The public may also attend the me eting at Kakuhihewa Building\, 601 Kamokila Blvd.\, Kapolei\, Hawaii\, C onference Room 511A\, where an audiovisual connection will be provided f or the public to view and participate in the meeting.

AGENDA \;

\ n
I.& nbsp\; \; \; \; \; \; \; \; \; \;&nb sp\; \; \; \; \; \; \; \; \; Call to Order\; Roll Call and Determination of Quorum
\n
II.&nb sp\; \; \; \; \; \; \; \; \; \; \; \; \; \; \; \; \; Approval of M inutes from the May 13\, 2026\, DUR Board Meeting
\n
III. \;&n bsp\; \; \; \; \; \; \; \; \; \;&nbs p\; \; \; \; Old business
\n
\;A.& nbsp\; \; \; \; \; ~~Board members&rsquo\; e xtension of terms approved\; Vacant pharmacist member\, searching for ph armacist with neighbor island community pharmacy background~~
\n
\;B. \; \; \; \; \; Update on DUR B oard member bylaws with practicing dentist member
\n
\;C.&nb sp\; \; \; \; \; U.S. Centers for Medicare and Medicaid Annual DUR Survey
\n
1. \; \; \; \; \; Prescription Drug Monitoring Program (PDMP) upda tes
\n
2. \; \; \; \; \; Retr ospective DUR program
\n
\;D. \; \; \; \; Dental Program
\n
1. \; \; \; \;&nb sp\; Outlier controlled substance prescriber
\n \;E. \; \; \; \; \; State of Hawaii Organ and Tissue Transplant program
\n
1. \; \; \;& nbsp\; \; Expensive drug claims review
\n
IV.&nb sp\; \; \; \; \; \; \; \; \; \; \; \; \; \; \; New Business
\n
\;A. \; \; \; \; \; Educational Outre ach Quarterly FFS provider bulletin
\n
1. \; \; \;& nbsp\; \; Resources for pain management prescribing co nsiderations: \;
\n
~~a. \; \; \; \; \;~~ The CDC Clinical Pr actice Guideline for Prescribing Opioids for Pain &mdash\; United States \, 2022 | MMWR \;https://www.cdc.gov /mmwr/volumes/71/rr/rr7103a1.htm \;provides CDC's most up dated recommendations for clinicians providing pain care for outpatients aged 18 years and over. \; \;The guidance addresses four areas: \; \;1) determining whether to initiate opioids for pain\, 2) s electing opioids and determining opioid dosages\, 3) deciding duration o f initial opioid prescription and conducting follow-up\, and 4) assessin g risk and addressing potential harms of opioid use.
\n
b. \; \; \; \; \; Acute Dental Pain Management Guideline | American Dental Association \;https://www.ada.org/resources/research/science/evidence- based-dental-research/pain-management-guideline \;provides ADA's most updated guidelines on acute dental pain management for adults and adolescents (2024) and pediatrics (2023)\, including evidence-based reso urces for the clinician.
\n
2. \; \; \; \; \; Safe opioid prescribing practices: \; \;
\n
a. \; \; \; \; \; https://hawaii.pmpaware.net \;Under the F ederal SUPPORT Act (Substance Use-Disorder Prevention that Promotes Opio id Recovery and Treatment for Patients and Communities Act)\, Medicaid p roviders must check\, before prescribing a controlled substance\, the pr escription drug history of a Medicaid beneficiary in the Hawaii PDMP (AK A HI PMP AWARxE)
\n
b. \; \; \; \; \; https://stacks.cdc.gov/view/cdc/38481/cdc_38481_DS1.pdf \;Downl oad URL for CDC guidelines: \; \;Calculating Total Daily Dose of Opioids for Safer Dosage
\n
c. \; \; \; \; \ ; \; CDC Updated 2022 Morphine Milligram Equivalents C alculator - GlobalRPH \;https://globalrph.com/medcalcs/m orphine-milligram-equivalents-calculator/ \;calculator provides estimates of equianalgesic dose of morphine for common opioids
\n
3. \; \; \; \; \; Naloxone nasal:
\n
a. \; \; \; \; \; Naloxone na sal is also available at various locations across the state of Hawaii th rough vending machines\, at no charge to the public. \; \;Check out Hawaii Health &\; Harm Reduction Center website at \;https://www.hhhrc.org \;for more information on v ending machine locations and other information on naloxone nasal accessi bility and usage. \;
\n
4. \; \; \; \; \; Safe disposal of unwanted medications
\n
a. \; \; \; \; \; Take Back Program at \; https://manoa.hawai i.edu/c3od2a/take-back/ \;shows locations on every island to dro p off unneeded or found medications
\n
< !-- [if !supportLists]--> b. \; \; \;&nb sp\; \; If a medication take-back program is not avail able nearby\, go to \;https://www .fda.gov/drugs/safe-disposal-medicines/disposal-unused-medicines-what-yo u-should-know \;for medications that can be safely flushed down the toilet. \; \;This list includes a small number of medicines that may be especially harmful and\, in some cases\, fatal with just one dose if they are consumed by pets or by someone other than the person f or whom the medicine was prescribed.
\n
c. \; \; \;&n bsp\; \; \; If the medication is not on the &ldquo \;Flush list&rdquo\;\, mix with dirt\, cat litter\, or coffee grounds.&n bsp\; \;Then seal in a container or plastic bag and throw away in yo ur household rubbish.
\n
\;B. \; \; \; \;&nb sp\; Hepatitis C treatment guidelines and health plan requ irements
\n
~~\;C. \; \; \; \; \; Potential effects of utilization management from H.R. 1 Act commun ity engagement requirements~~
\n
V. \; \; \; \; \; \; \; \; \; \; \; \; \; \; \; \; \; Public Testimony regarding topics pertinent to the FFS DUR Board\, limited to 3 minutes per speaker
\n
VI.&nb sp\; \; \; \; \; \; \; \; \; \; \; \; \; \; \; Next meeting will \;&nb sp\;be held on Wednesday\, November 18\, 2026
\n
VII. \; \;& nbsp\; \; \; \; \; \; \; \; \; \;&nb sp\; Adjourn
\n
\;
\n
All interested person s shall have an opportunity to submit data\, views\, or arguments\, in w riting\, and an opportunity to present oral testimony to any agenda item . \; \;Any person providing oral testimony is requested to submi t the remarks\, or a summary of the remarks\, in writing to the board\, no later than 48 hours prior to the meeting and shall state the item on which the testimony is being presented. \; \;The board provides for oral testimony of three minutes.
\n
\;
\n
Written testimony may be emaile d to MQDDURBoard@dhs.hawaii.gov or sent by U.S. Postal Mail to Departmen t of Human Services\, Med-QUEST Division\, Attn: \; \;Drug Use R eview Board\, P.O. Box 700190\, Kapolei\, HI 96709-0190.
\n
&nb sp\;
\n
NOTICE:&nbs p\; \;Written testimony submitted will be made public record and any contact information contained therein will be available for public insp ection and copying. \; \;Please do not include information in yo ur testimony that you do not want to be disclosed to the public.\n
\;
\n
NOT E: \; \;If you need auxiliary aid/service or other accommodation due to disability or limited English proficiency\, please contact: \; \;Med-QUEST Division at (808) 692-8124 (voice)\; or 711 (TTY) or by email at MQDDURBoard@dhs.hawaii.gov by 12:00 p.m. on Monday\, August 10\, 2026. Requests made as early as possible have a greater chance of b eing fulfilled due to a limited number of communication access providers .
\n
\;
\n
TEAMS VIRTUAL MEETING INFORMATION
\n
Topic: \; \; \; \; \; \; \; \; \; \; \; \; \; \;&n bsp\;Med-QUEST DUR Board Meeting
\n
Date/Time: \; \; \; \; \;&nbs p\;August 12\, 2026\, 12:00 noon (HST)
\n
\;
\n
Register in advance f or this meeting:
\n
https://even ts.gcc.teams.microsoft.com/event/61990eac-11d3-490d-99d9-475433cd67c1@38 47dec6-63b2-43f9-a6d0-58a40aaa1a10
\n
\;*Note\, virtual meeting will be hos ted via \;Teams \;Application
\n